parkinson's disease retatrutide clinical trial Insights into Trials in 2022: Recent Advances Parkinson's Disease Clinical Trial Triumph-1 Trial Results for Retatrutide

Hosseini R, Ferns GA, Sahebkar A, Mirshekar MA, Jalali M

Membranes were stripped for 20 min at room temperature using a Blot Restore Membrane Rejuvenation kit (Sigma-Aldrich, 2520-M), then washed twice with TBS-T, re-blocked with BSA 5% for 30 min and incubated with mouse-anti--actin (Sigma-Aldrich, A1978) 1:3,000 in BSA 2.5% for 4 h at room temperature and then incubated with a sheep-anti-mouse (Amersham, NA931) secondary antibody at 1:5,000 in BSA 2.5% for 2 h

A core omnigenic non-coding trait governing Dex-induced osteoporotic effects identified without DEXA

Adding Unmovable Bulk: Fiber is a "bulk-forming" laxative

Do they help with inflammation in joints